S100B and Mental deterioration: Moreover, the study suggests that remazolam may have neuroprotective properties by mitigating neuroinflammation and oxidative stress, key contributors to POCD pathogenesis.[18,20] The observed reductions in inflammatory markers, such as IL-6 and S100β, indicate its potential to protect against cognitive decline.